APA (7th ed.) Citation

KCR, S., JM, R., VM, Z., JRI, C., CB, M., CM, M., . . . ACP, d. F. (2021). When Leptin Is Not There: A Review of What Nonsyndromic Monogenic Obesity Cases Tell Us and the Benefits of Exogenous Leptin. Frontiers in endocrinology, 12, 722441. https://doi.org/10.3389/fendo.2021.722441

Chicago Style (17th ed.) Citation

KCR, Salum, Rolando JM, Zembrzuski VM, Carneiro JRI, Mello CB, Maya-Monteiro CM, Bozza PT, Kohlrausch FB, and da Fonseca ACP. "When Leptin Is Not There: A Review of What Nonsyndromic Monogenic Obesity Cases Tell Us and the Benefits of Exogenous Leptin." Frontiers in Endocrinology 12 (2021): 722441. https://doi.org/10.3389/fendo.2021.722441.

MLA (9th ed.) Citation

KCR, Salum, et al. "When Leptin Is Not There: A Review of What Nonsyndromic Monogenic Obesity Cases Tell Us and the Benefits of Exogenous Leptin." Frontiers in Endocrinology, vol. 12, 2021, p. 722441, https://doi.org/10.3389/fendo.2021.722441.